Publicacions en què col·labora amb Jesús Castilla Catalán (31)

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

  2. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2007

  1. Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): Metodología y primeros resultados

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 1, pp. 23-31

  2. Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters

    Gaceta Sanitaria, Vol. 21, Núm. 1, pp. 76-83

2004

  1. Consensus conference on chronic viral hepatitis and HIV infection: Updated Spanish recommendations

    Journal of Viral Hepatitis

  2. Impact of chronic hepatitis C on HIV-1 disease progression

    HIV Clinical Trials, Vol. 5, Núm. 3, pp. 125-131

2003

  1. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: Differences by transmission category

    AIDS, Vol. 17, Núm. 3, pp. 353-359

2002

  1. Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

    Sexually Transmitted Infections, Vol. 78, Núm. 4, pp. 255-260

  2. Management of chronic viral hepatitis in HIV-infected patients: Spanish consensus conference

    HIV Clinical Trials, Vol. 3, Núm. 2, pp. 99-114

2001

  1. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays

    Journal of Medical Virology, Vol. 64, Núm. 3, pp. 217-222

1999

  1. Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.

    AIDS (London, England)

1998

  1. Interrelación entre la duración de la infección por el virus de la inmunodeficiencia humana, la viremia plasmática y la cifra de linfocitos CD4+

    Medicina Clinica, Vol. 110, Núm. 14, pp. 529-531

  2. Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients [3]

    Journal of Hepatology

  3. The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load

    Journal of Infection, Vol. 36, Núm. 3, pp. 307-311

1997

  1. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 35, Núm. 3, pp. 225-230

  2. Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy [4]

    European Journal of Clinical Microbiology and Infectious Diseases

  3. Co-infection with several HCV genotypes enhances liver damage in patients with chronic hepatitis C [3]

    Journal of Infection